Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area of oncology with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has promising product candidates in clinical and late preclinical development and has entered into strategic collaborations with leading global pharmaceutical companies.
Recent News > MORE
Upcoming and Recent Events > MORE
|Summary Toggle Thursday, June 14, 2018 8:00 AM PDT||
|Summary Toggle Thursday, June 07, 2018 11:00 AM EDT||
Chief Strategy Officer and Secretary
|Summary Toggle Tuesday, May 08, 2018 4:30 PM EDT||